Site icon CMS Compliance Group

Ftag of the Week – F886 re COVID-19 Testing (Part 1)

In an August 26, 2020 QSO Memo, the Centers for Medicare & Medicaid Services (CMS) provided several policy and regulatory revisions related to COVID-19 and long-term care facility testing requirements. This is the third Ftag that CMS has added to the Infection Control regulatory group since the beginning of the COVID-19 Public Health Emergency (PHE). F886 requires nursing homes to test all residents and staff for COVID-19. Here are some of the specifics:

Testing Parameters

Testing must be conducted based on the parameters set out by the Health and Human Services (HHS) Secretary, including:

Testing must be conducted in a manner consistent with established best practices for COVID-19 testing.

Per the Interpretive Guidance included in the QSO Memo, facilities can meet the testing requirements by using rapid point-of-care tests or by making arrangements with an off-site laboratory. Facilities that wish to conduct their own tests must have a CLIA Certificate of Waiver. If a facility cannot conduct COVID-19 POC testing, it should make arrangements with a lab to conduct the tests as per the requirement.

Who Needs to be Tested

All residents and facility staff, including employees, consultants, contractors, volunteers and caregivers who provide care and services to residents on behalf of the facility, as well as students from affiliated academic institutions and student in the facility’s nurse aide training programs must be tested.

A Testing Summary table has been included in the QSO Memo. These are the parameters:

Preventing Transmission

Test Refusals – Staff

Test Refusals – Residents

When There is a Supply Shortage

Facilities, if necessary, are expected to contact state and local health departments to assist in testing efforts if there is an emergency such as a supply shortage of testing materials, difficulty obtaining testing supplies, or difficulty processing test results.

Screening

Screening should continue, regardless of testing or COVID-19 status of the facility, per the IG. Specifically:

The above information is a lot to digest, and not even all of the information that providers need to know. Stay tuned for Part 2 of our Ftag of the Week – F886 for information on conducting testing, documentation, and reporting requirements.  The COVID-19 saga continues!

To review the QSO Memo, “Interim Final Rule (IFC), CMS-3401-IFC, Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency related to Long-Term Care (LTC) Facility Testing Requirements and Revised COVID-19 Focused Survey Tool” (QSO-20-38-NH) in full, please click here.

Exit mobile version